Sir Sandy Macara, former chairman of the British Medical Association (BMA) and Head of the Department of Epidemiology and Public Health Medicine at Bristol University, has died aged 80. Professor Jonathan Sterne, from the School of Social and Community Medicine, offers this tribute.
A new study carried out by academics in the University's School of Clinical Sciences has found feeling the pain of a heart attack could actually help the heart minimise damage.
Three academics at the University of Bristol have been appointed NIHR Senior Investigators by the National Institute for Health Research (NIHR).
In addition to the many risk factors associated with poor health, reducing body mass index (BMI) will have a considerable and independent impact if you want to reduce the risk of developing ischemic heart disease (IHD). This is the key finding from new research, published in PLoS Medicine, which evaluated the causal relationship between BMI and heart disease in 76,000 individuals.
The number of people using insulin to treat diabetes trebled between 1991 and 2010, researchers from the Universities of Bristol and Cardiff have found.
The British Dental Students’ Association (BDSA) 2012 conference, hosted by the University's Dental School, will take place from Thursday 15 to Saturday 17 March.
New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease. The University of Bristol-led research is published in Cardiovascular Diabetology.
Dr Pat Kehoe, Reader in Translational Dementia Research in the School of Clinical Sciences at the University of Bristol, has been invited to join the Research Advisory Committee (RAC) of the Alzheimer's Society.
A detailed study of intimate partner violence and abuse (IPVA) among young people in the UK has found that a 'loneliness loop' risks trapping young people in a repeating cycle of abuse. The University of Bristol-led research, which analysed survey data from 3,000 young people, recommends early intervention to prevent young people from experiencing IPVA.
Our genes control many aspects of who we are — from the colour of our hair to our vulnerability to certain diseases — but how are the genes, and consequently the proteins they make themselves controlled? Researchers have discovered a new group of molecules which control some of the fundamental processes behind memory function and may hold the key to developing new therapies for treating neurodegenerative diseases.
